These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11235863)

  • 1. Restlessness related to SSRI withdrawal.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRI discontinuation syndrome related to fluvoxamine.
    Benazzi F
    J Psychiatry Neurosci; 1998 Mar; 23(2):94. PubMed ID: 9549249
    [No Abstract]   [Full Text] [Related]  

  • 3. Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
    Won M; Minabe Y; Sekine Y; Takei N; Kondo N; Mori N
    J Psychiatry Neurosci; 2003 Mar; 28(2):134-5. PubMed ID: 12670131
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential withdrawal syndrome associated with SSRI discontinuation.
    Lazowick AL; Levin GM
    Ann Pharmacother; 1995 Dec; 29(12):1284-85. PubMed ID: 8672834
    [No Abstract]   [Full Text] [Related]  

  • 5. Complex movement disorder associated with fluvoxamine.
    Bronner IM; Vanneste JA
    Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin syndrome and fluvoxamine: a case study.
    Bastani JB; Troester MM; Bastani AJ
    Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Bakker A
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased libido in a woman treated with fluvoxamine: a case report.
    Hori H; Yoshimura R; Nakamura J
    Acta Psychiatr Scand; 2001 Apr; 103(4):312-4. PubMed ID: 11328247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discontinuation syndrome after SSRI antidepressants].
    Lykkegaard LA; Videbech P
    Ugeskr Laeger; 2014 Feb; 176(3):231-5. PubMed ID: 24629750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 13. A display of hypomania in a depressed male in response to fluvoxamine.
    Horiguchi T; Sai S
    World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.
    Apter A; Ratzoni G; King RA; Weizman A; Iancu I; Binder M; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):342-8. PubMed ID: 8169178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The abrupt discontinuation of fluvoxamine in patients with panic disorder.
    Black DW; Wesner R; Gabel J
    J Clin Psychiatry; 1993 Apr; 54(4):146-9. PubMed ID: 8486592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delirium following abrupt discontinuation of fluoxetine.
    Blum D; Maldonado J; Meyer E; Lansberg M
    Clin Neurol Neurosurg; 2008 Jan; 110(1):69-70. PubMed ID: 17913343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J; Keegstra H; Barrelet L
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction.
    DE Berardis D; Serroni N; Marini S; Fornaro M; Valchera A; Martinotti G; DI Giannantonio M; Kahn DA
    J Psychiatr Pract; 2014 May; 20(3):228-31. PubMed ID: 24847997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.